Diagnostic Metabolomic Profiling of COPD as Potential Biomarkers in Older and Younger Patients
Metabolomic biomarkers for COPD diagnosis across ages
Diagnostic gap and rationale for blood-based metabolomics in COPD
Currently, Chronic Obstructive Pulmonary Disease (COPD) has high levels of underdiagnosis (>60% in the United States and Europe) despite being the third leading cause of death worldwide. The analysis of blood metabolite composition can improve diagnostic accuracy and offer deeper insights into the molecular pathophysiology of COPD. Sadly, most of the studies lack including important emerging groups of patients (young COPD and women). In this study, plasma metabolomic profiling was conducted to identify disease-related metabolic biomarkers associated with COPD.
Implications and next steps in biomarker validation
We identified significantly altered metabolite profiles in COPD patients compared to healthy controls, highlighting specific metabolites that exhibited potential as discriminative biomarkers and providing novel insights into COPD pathogenesis. Future validation and mechanistic studies are still needed.
Authors
C.J. Enríquez Rodríguez, C. Casadevall, I. Abramovich, B. Agranovich, M.R. Faner, E. Barreiro, C. Casanova Macario, A. Castro-Acosta, B.G. Cosio, J. Garcia Aymerich, J.L. Lopez Campos, E. Monso, S. Pascual-Guardia, G. Peces-Barba, S. Santos, L. Seijo, J.J. Soler Cataluna, A. Agusti, E. Gottlieb, J. Gea, BIOMEPOC BIOEARLY
Read more details at
Fecha de publicación
May 2025 (Publication date)
Categorías asociadas al artículo
Results:
Noticias relacionadas
Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients
This study identifies a metabolic signature of COPD patients, involving fatty acids, amino acid and carbohydrate metabolites, using LC-MS plasma profiling.
Alteraciones espirométricas y sus factores de riesgo en la población joven ambulatoria
Un estudio reciente en Osona (Cataluña) refleja que 20,7% de jóvenes presenta alteraciones espirométricas. También revela síntomas y factores de riesgo en la población joven ambulatoria.
II edición RESPrimaria, 7 de mayo de 2025
No te pierdas la II edición RESPrimaria el próximo 7 de mayo. Inscríbete en formato Streaming o solicita tu invitación presencial. ¡Plazas limitadas!
Entrevista SEMG al Dr. Alvar Agusti, Experto en la II Jornada Resprimaria
Descubre los avances en el diagnóstico y tratamiento de la EPOC con el Dr. Alvar Agustí en la II Jornada SEMG Resprimaria. Conoce la importancia de la espirometría, la detección precoz y las nuevas estrategias terapéuticas.
Falling through the cracks: what happens to survivors of preterm birth?
Survivors of preterm birth face increased risks of respiratory diseases, yet awareness among specialists is low. This study examines gaps in long-term care, highlighting the need for clear follow-up guidelines and improved communication between medical teams.
Aging and Metabolic Changes in COPD Patients
Explore the metabolic changes in COPD patients, highlighting the influence of aging and sex, with pronounced effects in males. Discover how COPD affects protein metabolism and energy production, emphasizing early aging’s impact.
Imagen desarrollada DALL·E y Canva